. Liu X, Zhang Q, Guo H, Pan Q, Zhou K. Bendamustine, gemcitabine, and vinorelbine
(BeGEV) regimen followed by ASCT induces durable remissions in PD-(L)1
inhibitor-resistant refractory/relapsed classical Hodgkin lymphoma: a
single-center, long-term stud Blood 2026;147:703.
PMID: 41642603
|